Improved early course after cadaveric renal transplantation by reducing the cyclosporine dose and adding azathioprine.
D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003080:Cold Temperature; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007239:Infections / Q000209:etiology; D007511:Ischemia; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011897:Random Allocation; D013997:Time Factors; D014021:Tissue Preservation
D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine